The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor.
Gerrits CJ, Schellens JH, Creemers GJ, Wissel P, Planting AS, Pritchard JF, DePee S, de Boer-Dennert M, Harteveld M, Verweij J.
Gerrits CJ, et al. Among authors: creemers gj.
Br J Cancer. 1997;76(7):946-51. doi: 10.1038/bjc.1997.490.
Br J Cancer. 1997.
PMID: 9328158
Free PMC article.
Clinical Trial.